Hastings Technology Metals Limited Overview
Hastings Technology Metals is a Perth-based, pre-revenue rare earths company. It is moving from being the 100% owner of a single development asset to holding a portfolio of minority and joint-venture interests across the rare earths mine-to-intermediate chain. Its core asset is a 40% participating interest in the Yangibana Rare Earths and Niobium Project in Western Australia's Gascoyne region, operated by Andrew Forrest's Wyloo (60%). Yangibana is one of the higher-NdPr-ratio hard-rock deposits globally: NdPr averages 37% of TREO, and the July 2026 Updated DFS put Stage 1 pre-tax NPV8 at A$649M. In 2026 Hastings opened a second pillar, a binding term sheet to acquire 49% of a permitted hydrometallurgical plant at Kabin Buri, Thailand, which will convert monazite into mixed rare earth chloride (MREC). The company also holds the early-stage Brockman project. Its investment case rests on near-term midstream cash flow from Thailand, a re-rating of Yangibana through Wyloo's sale process, and Western demand for non-Chinese rare earths supply.
Company's own description
Across 2026 ASX releases, Hastings describes itself as a Perth-based rare earths company focused on rare earth elements and critical minerals used in electric vehicles, renewable energy, humanoid robotics, medical applications and digital devices. The July 2026 quarterly reframes its ambition as becoming an integrated "mine-to-MREC" producer. Older website text (last modified June 2025) still describes Yangibana as 100% owned and lists a 21.5% Neo Performance Materials stake. Both statements are out of date: Yangibana moved into the Wyloo joint venture in 2025, and the Neo shares were sold or transferred during 2025.
Independent characterisation
Hastings is a pre-production, pre-revenue resource development holding company. It has reported no operating revenue in any of the last five fiscal years, apart from immaterial other revenue of A$0.06M in FY2021 and A$2.27M of interest and investment income in FY2025. Its economic exposure is concentrated in three assets:
-
Yangibana JV (40%). This is a non-operated interest in a permitted open-pit mine and beneficiation project. It is designed to produce about 37,000 tpa of mixed rare earth concentrate in Stage 1. Hastings funds 40% of JV expenditure. Wyloo is manager and operator and holds an option to move to 70%.
-
Kabin Buri Hydromet Plant, Thailand (49%, pending completion). This is a midstream processing facility that cracks and leaches monazite concentrate into MREC flake, an intermediate product sold to oxide separation plants. Under the term sheet, Hastings will control the board and Enuo Holdings will run day-to-day operations.
-
Brockman project (100%). This is an exploration-stage rare metals and heavy rare earths project in the East Kimberley, WA, hosting zirconium, niobium, tantalum and yttrium mineralisation. Niobium recovery testwork is under way.
Business and revenue model
| Model element | Current state (Oct 2026) | Target state |
|---|---|---|
| Revenue model | None (pre-revenue) | Product sales: MREC flake from Thailand (Hastings' 49% share via an equity-accounted or consolidated vehicle, structure not yet disclosed); 40% share of Yangibana concentrate sales |
| Product vs service mix | 100% product (prospective) | MREC (chemical intermediate) and mineral concentrate |
| Subscription / licensing | — | None disclosed. The Ucore HoA references potential use of Yangibana JV proprietary hydromet technology in a US plant, so licensing could emerge but is unconfirmed |
| Value chain position | Upstream (mining/beneficiation) via the JV; midstream (cracking/leaching) via Thailand | Mine → concentrate → MREC → (third-party) separation → magnet makers |
| Customer types | Prospective: oxide separation refiners (e.g., Ucore Louisiana SMC under a non-binding HoA), trading houses and Asian separators | Same |
| End markets | NdFeB permanent magnets for EV traction motors, wind turbines, robotics, consumer electronics, defence and industrial motors | Same |
Value chain economics
According to the July 2026 Updated DFS, NdPr is expected to contribute more than 90% of Yangibana revenue. Asset value is therefore leveraged to NdPr oxide prices. The Thai plant's feedstock is African monazite (≥54% TREO, with NdPr about 20% and minor Dy/Tb, per the April 2026 release). Its margin depends on the spread between monazite purchase cost and MREC sale price. The company cites Shanghai Metals Market (SMM) data showing chloride flake selling at roughly a 20% premium to carbonate equivalents.
Strategy
Stated strategy themes (2026 releases and presentations)
-
"Mine-to-MREC" integration. Hastings aims to move from pure upstream development to an integrated producer through the Thai plant, which it describes as a capital-light, near-term pathway to revenue ahead of Yangibana.
-
Near-term producer by end-2026. The May 2026 presentation is titled around becoming a near-term producer by end-2026. In July 2026 the target moved to Q1 CY2027 when expanded capacity was incorporated into the initial build.
-
Yangibana value realisation. The 2026 Updated DFS re-based Stage 1 with an owner-operator mining model and existing infrastructure. Wyloo's sale process introduces a potential new 60% partner.
-
Allied-jurisdiction supply chains. Hastings is positioning around the US–Australia critical minerals framework (Ucore HoA) and the October 2025 US–Thailand critical minerals MOU.
-
Portfolio simplification. It exited gold and Neo to focus on rare earths and niobium.
Initiative register (last 24 months)
| Initiative | Date | Description | Targets / status |
|---|---|---|---|
| Yangibana JV with Wyloo | Feb–Sep 2025 | 60/40 unincorporated JV; debt cancelled | Completed |
| Gold divestment to Metal Bank | Signed 2025; completed 5 Dec 2025 | 160.0M MBK shares, distributed in specie | Completed |
| Neo stake exit | Feb–Oct 2025 | A$79.8M sale to Wyloo plus residual sale | Completed |
| Ucore offtake and US hydromet HoA | 31 Oct 2025 | Up to 37,000 tpa concentrate; evaluate a Louisiana hydromet | Definitive agreement was targeted by June 2026; not confirmed as executed |
| Enuo Technical Services and Research Agreement | Jan 2026 | Metallurgical testwork on Yangibana and Brockman ore | Ongoing |
| Thai Hydromet Plant (49%) | 31 Mar 2026 | Consideration capped at US$15M: US$8M equity, deferred payments of about US$5.5M in three annual instalments subject to performance, commissioning funded by Enuo | Completion subject to final documents |
| African monazite feedstock | 14 Apr 2026 | Two-year framework offtake, initially 5,000 tpa; later a minimum of 10,000 tpa | Executed |
| Thai capacity doubling | 14 Jul 2026 | 12,000 tpa MREC in initial build; potential 36,000 tpa from 2028 | Engineering and groundworks |
| Thai BOI incentives | 2,026 | Applying for Board of Investment tax incentives | Pending |
| Updated Yangibana DFS | 13 Jul 2026 | Stage 1 economics re-based | Completed |
| Brockman niobium testwork | 2,026 | Recovery testwork | Ongoing |
| Saudi Arabia downstream opportunity | Flagged Feb 2025 | Hydromet and magnet processing concepts | No update verified |
Management targets and guidance
| Target | Guidance | Source |
|---|---|---|
| First MREC production, Thailand | Q1 CY2027 (previously Q4 CY2026) | June 2026 quarterly |
| Thai capacity | 12,000 tpa MREC initial; 36,000 tpa potential from 2028 | 14 Jul 2026 |
| Yangibana Stage 1 | Capex A$333.4M (Hastings share about A$133M); 2.4-year payback; average annual earnings A$108M after royalties | Updated DFS |
| Yangibana FID | Targeted within about 18 months (media, H1 2026) | Mining.com / AFR |
| Medium-term financial targets (revenue, margin) | Not publicly disclosed beyond indicative Thai projections | — |
Products & Services
Hastings sells no commercial product today. The catalogue below lists every prospective product and asset-level offering disclosed.
Yangibana JV products (Hastings 40%)
| Product | Description | Key specifications | Target customer | Timing | Pricing model |
|---|---|---|---|---|---|
| Mixed rare earth concentrate (Stage 1) | Beneficiated concentrate from open-pit ore | About 37,000 tpa concentrate; plant nameplate 1.2 Mtpa ore; reserves 20.93 Mt @ 0.90% TREO; NdPr 37% of TREO (up to 52% locally) | Hydromet/separation refiners, e.g., Ucore Louisiana SMC (HoA up to 37,000 tpa); potentially the Kabin Buri plant | Updated DFS 13 Jul 2026; FID not taken; Wyloo has said about 18 months from FID to concentrate | Market-linked to NdPr pricing (not disclosed) |
| Mixed rare earth carbonate / intermediate (Stage 2) | Hydromet product from cracking, leaching and precipitation of concentrate | Not specified in the 2026 DFS, which covers Stage 1 only. The 2022 economics assumed about 15,000 t/y MREC containing about 3,400 t/y NdPr | Separators | Deferred; options include Thailand, a US (Louisiana) hydromet, or a WA hydromet | — |
| Niobium by-product | Niobium in Yangibana ore | Not quantified in sources retrieved | Steel/alloy producers | Studies | — |
| Hafnium-rich zircon (Bald Hill) | Referenced in FY2024 Annual Report | Not quantified | Specialty materials | Concept | — |
Kabin Buri Hydromet Plant products (Hastings 49%)
| Product | Description | Key specifications | Target customer | Timing | Pricing |
|---|---|---|---|---|---|
| Mixed Rare Earth Chloride (MREC) flake | Seven-stage process: caustic cracking of monazite, HCl leaching, purification, crystallisation into flake | Phase 1 nameplate originally 5,000 tpa monazite feed (about 6,000 tpa MREC). Expanded initial build is 10,000 tpa feed / 12,000 tpa MREC, with potential 36,000 tpa from 2028 (Jul 2026 release) | Global oxide separation plants | First production retargeted from Q4 CY2026 to Q1 CY2027 | Linked to the SMM rare earth chloride index and oxide basket prices; chloride flake trades at roughly a 20% premium to carbonate (company citing SMM) |
| Toll or third-party processing | Processing Yangibana or third-party concentrate | Plant modular and expandable | Yangibana JV (subject to JV assessment), Enuo | Optional | — |
Indicative economics (unaudited, company projections, 22 April 2026). Media coverage reported a first-year revenue target of about US$53M at the earlier capacity. These projections are not reserves-based. They are marked indicative and unaudited by the company and depend on commissioning success.
Brockman project (100%)
| Asset | Commodities | Stage | Latest activity |
|---|---|---|---|
| Brockman Rare Earths and Niobium Project, East Kimberley, WA | Zirconium (zircon), niobium, tantalum, heavy rare earth yttrium | Exploration / metallurgical testwork | Niobium recovery testwork (March 2026 quarterly); Enuo testwork agreement (Jan 2026) |
Divested offerings (for completeness)
| Asset | Status |
|---|---|
| Whiteheads Gold Project | Sold to Metal Bank (completed 5 Dec 2025) |
| Ark Gold / Darcy's | Sold to Metal Bank (completed 5 Dec 2025) |
| Neo Performance Materials stake (magnets and processing) | Fully exited during 2025 |
Financial Narrative
Basis. These are audited consolidated results for FY2021–FY2025 (years to 30 June), sourced from the annual reports as reproduced by StockAnalysis, Barchart and TipRanks (aggregator). The H1 FY2026 figures come from the Interim Financial Report lodged 13 March 2026.
Income statement
Notes. Barchart reports FY2021 basic EPS of -0.09 against -0.10 elsewhere; the difference is rounding. Aggregator operating expense definitions differ: Barchart shows FY2025 operating expenses of A$46.6M because it includes part of the impairment. The StockAnalysis split is used here. EBITDA is not meaningful. TipRanks' calendar-labelled EBITDA series is inconsistent with the June fiscal year and is not used.
Margins and growth
Gross, operating, EBITDA and net margins are not meaningful because revenue is nil, and the revenue CAGR is undefined. The meaningful trend is the loss trajectory. Net loss widened from A$6.3M (FY2021) to A$33.8M (FY2024), driven by interest on the Wyloo exchangeable notes and project financing, which took interest expense to A$34.5M in FY2024. It then jumped to A$222.1M in FY2025 on the A$176.4M Yangibana impairment recognised on the Wyloo JV transaction. Net loss growth rates (Barchart) were -49.9%, -49.0%, -12.1%, -219.4% and -557.3% for FY2021–FY2025.
Balance sheet
Implied total debt is derived as cash and short-term investments minus net cash. FY2025 current assets include about A$119.4M of other current assets, consistent with gold assets held for sale and related items.
H1 FY2026 (31 Dec 2025): cash A$4.93M; total assets A$104.59M; net debt A$0.69M (implied debt about A$5.6M); net loss A$2.21M versus A$164.1M in H1 FY2025, including a A$0.81M gain on disposal of the gold assets and a A$0.16M fair-value gain (Interim Report, 13 Mar 2026).
June 2026 quarter (Appendix 5B): closing cash about A$3.76M after net operating outflows of A$1.13M.
Cash flow
Capex was heavy in FY2022–FY2024, consistent with PP&E rising from A$110.9M to A$371.7M (about A$261M of cumulative additions). Free cash flow was deeply negative in those years. Recent quarterly operating outflows were A$1.3M (March 2026 quarter) and A$1.13M (June 2026 quarter), plus A$1.5M of investing outflows in the March quarter.
Capital management, non-cash. In December 2025 Hastings made an in-specie distribution of MBK shares to its shareholders, a capital return in kind.
Ratios
ROA is derived as net income divided by year-end total assets. ROE (TTM) is quoted by aggregators at -53.8% (AllInvestView) and -67.8% (Wisesheets, May 2026). Debt/equity of 6.08 is quoted by AllInvestView, but it is inconsistent with the low post-JV debt, so treat it with caution.
Commentary
FY2021–FY2022: well-funded developer. Equity raisings left about A$110–135M of cash and investments. Losses were modest at A$6–9M, reflecting corporate and pre-development costs.
FY2023–FY2024: leverage and capital deployment. The Wyloo exchangeable notes and construction-readiness spending (airstrip, a 294-room village, borefields and long-lead items) took debt to about A$135–169M and interest to A$20–34M a year. The Neo stake (about A$81–84M) was an attempted mine-to-magnet integration move, but it tied up capital while project financing remained incomplete. Cash fell from A$98.6M to A$17.9M during FY2024.
FY2025: inflection through restructuring. The Wyloo dispute led to the JV. Wyloo took 60% and operatorship, the notes were cancelled, and Neo shares were transferred to Wyloo. Hastings wrote down Yangibana by A$176.4M, crystallising a A$222.1M loss but removing almost all debt.
FY2026: asset-light and cash-thin. Hastings exited gold and Neo. H1 losses fell to A$2.2M, a 99% reduction on the prior period. Liquidity is the binding constraint: quarterly cash fell to about A$3.8M by June 2026 against a 40% share of Yangibana Stage 1 capex of about A$133M (DFS) and Thai deferred consideration. Further dilution or asset-level financing is highly likely.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Revenue
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Rare earths exploration and evaluation, Australia (AUD Mn) | 0 | 0 | 0 |
Gold assets, discontinued (AUD Mn) | 0 | 0 | 0 |
Thailand processing (AUD Mn) | 0 | 0 | 0 |
Total operating revenue (AUD Mn) | 0 | 0 | 0 |
Entity / Interest Details
| Entity / interest | Ownership | Asset | Status |
|---|---|---|---|
Hastings Technology Metals Ltd | Listed parent | — | ASX: HAS |
Yangibana Jubilee Pty Ltd (subsidiary) | 100% | 40% participating interest in the Yangibana unincorporated JV | JV formed 2025; Wyloo Gascoyne Pty Ltd holds 60% and is manager |
Thai company owning the Kabin Buri plant | 49% (on completion) | MREC hydromet plant, Prachin Buri Province | Binding term sheet 31 Mar 2026; completion subject to final documentation |
Brockman project entity | 100% | Brockman rare earths and niobium project, East Kimberley WA | Exploration and testwork |
Gold subsidiaries (Great Western Gold, Ark Gold) | 0% (sold) | Whiteheads, Ark, Darcy's gold projects | Sold to Metal Bank, Dec 2025 |
Neo Performance Materials (TSX: NEO) | 0% (sold) | Previously about 21.5% | Transferred and sold Feb–Oct 2025 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue, operating (AUD Mn) | 0.06 | 0 | 0 | 0 | 0 |
Gross profit (AUD Mn) | 0.06 | 0 | 0 | 0 | 0 |
SG&A (AUD Mn) | 3.90 | 6.78 | 29.32 | 1.14 | 6.60 |
Total operating expenses (AUD Mn) | 6.49 | 9.74 | 30.19 | 3.95 | 7.70 |
Operating income (AUD Mn) | -6.43 | -9.74 | -30.19 | -3.95 | -7.70 |
Interest expense (AUD Mn) | 0.02 | 0.03 | 20.43 | 34.48 | 30.11 |
Interest and investment income (AUD Mn) | 0.11 | 0.33 | 7.17 | 5.57 | 2.27 |
Asset write-downs (AUD Mn) | 0 | 0 | 0 | 2.77 | 176.40 |
Pre-tax income (AUD Mn) | -6.33 | -9.44 | -10.58 | -33.27 | -222.21 |
Net income (AUD Mn) | -6.33 | -9.44 | -10.58 | -33.79 | -222.11 |
EPS basic and diluted (AUD) | -0.10 | -0.10 | -0.08 | -0.24 | -1.24 |
Weighted average shares (M) | 66.61 | 96.21 | 128.20 | 140.16 | 179.43 |
Dividends per share (AUD) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash and equivalents (AUD Mn) | 28.07 | 119.87 | 98.64 | 17.89 | 0.69 |
Short-term investments (AUD Mn) | 82.00 | 15.00 | 0 | 0 | 10.14 |
Cash and short-term investments (AUD Mn) | 110.07 | 134.87 | 98.64 | 17.89 | 10.83 |
Total current assets (AUD Mn) | 114.68 | 143.45 | 106.99 | 25.28 | 130.71 |
Property, plant and equipment (AUD Mn) | 110.87 | 154.56 | 302.45 | 371.68 | 91.91 |
Long-term investments, Neo stake (AUD Mn) | 0 | 0 | 83.90 | 81.27 | 0 |
Intangibles (AUD Mn) | 0.36 | 0.33 | 0.08 | 0.18 | 0.14 |
Total assets (AUD Mn) | 225.91 | 298.34 | 493.42 | 480.00 | 222.77 |
Net cash (debt) (AUD Mn) | 109.95 | 134.28 | -36.15 | -151.41 | -118.34 |
Implied total debt (AUD Mn) | 0.12 | 0.59 | 134.79 | 169.30 | 129.17 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net change in cash (AUD Mn) | 18.62 | 91.80 | -21.21 | -80.71 | -17.20 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Return on assets (%) | -2.8 | -3.2 | -2.1 | -7.0 | -99.7 |
Asset turnover (x) | 0 | 0 | 0 | 0 | 0 |
Interest coverage, EBIT/interest (x) | -321.5 | -324.7 | -1.5 | -0.1 | -0.3 |
Geographic Revenue
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Australia revenue (AUD Mn) | 0 | 0 | 0 |
Thailand / Asia revenue (AUD Mn) | 0 | 0 | 0 |
Americas revenue (AUD Mn) | 0 | 0 | 0 |
Total revenue (AUD Mn) | 0 | 0 | 0 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Latest price | About A$0.27 (late Sep 2026) | InvestSMART |
52-week range (ASX) | A$0.655 high (21 Jan 2026) to about A$0.26 low | ASX option notice; aggregators |
1-year return | About +28% (OTC USD, to Sep 2026) | Motley Fool US |
5-year return | About -92% | Motley Fool US; Pearler |
Since IPO | About -94% | Stoxray |
Metric | FY2022 | FY2023 |
Weighted average shares (M) | 96.21 | 128.20 |
Capital Markets
| Metric | Hastings | Comment |
|---|---|---|
P/E | n/m | Loss-making |
EV/EBITDA | n/m | Negative EBITDA |
EV/Sales | n/m | No sales |
P/B | About 0.61–0.65x | AllInvestView (book value about A$0.42 per share) |
Market cap / attributable DFS NPV | About A$62M versus about A$260M (40% × A$649M pre-tax, before funding) | About 0.24x; derived |
EV (Feb 2026) | US$157M against market cap US$75.7M | Multiples.vc. The EV likely includes stale debt data |
Source Details
| Source | Rating / target |
|---|---|
AllInvestView consensus | Mean target A$0.45 |
TipRanks (latest analyst) | Hold, A$0.35 target |
Coverage | About five analysts (Simply Wall St) |
Capital Markets — Dividend history
| Item | Status |
|---|---|
Dividend history | None paid; no dividend policy. In-specie MBK share distribution in Dec 2025 |
Buybacks | None authorised |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Debt maturity profile | Exchangeable notes (originally due Oct 2025) cancelled in 2025. Remaining debt is minor (about A$5.6M implied at Dec 2025, likely leases and loans) |
Recent equity | A$1.0M placement at A$0.365 (Jun 2026); HASO option conversions (Apr 2026). Historically: A$12M placement plus A$16.5M rights issue at A$0.17 with attaching options (Stockhead) |
Analyst Conclusions
Management guidance
-
First MREC from the Thai plant in Q1 CY2027, at a 12,000 tpa MREC capacity in the initial build.
-
Potential expansion to 36,000 tpa from 2028.
-
Yangibana Stage 1 FID within about 18 months, subject to the JV partner and financing.
-
No quantified group revenue or earnings guidance.
Consensus
Forward EPS is shown at about -A$0.03 (AllInvestView), implying a narrow loss as the company transitions. No consensus revenue estimates were verified.
Bull case
-
Deep discount to project value. Hastings' attributable pre-tax DFS NPV is about A$260M (40% of A$649M) against a market cap of about A$62M. A credible buyer for Wyloo's 60% at a full price would re-mark that value.
-
Self-funded bridge. Thai cash flow from 2027 at 12,000 tpa MREC could part-fund Yangibana equity calls and reduce dilution. Entry cost is capped at US$15M, largely in scrip and deferred payments.
-
Policy tailwinds. Western price floors and allied-jurisdiction frameworks (US–Australia, US–Thailand) make high-NdPr, permitted, infrastructure-ready Yangibana strategically scarce.
Bear case
-
Funding gap. Cash of about A$3.8M against an about A$133M Yangibana share plus Thai obligations implies heavy dilution or loss of further project interest, for example if Wyloo exercises its 70% option.
-
Execution risk. The never-commissioned Thai plant depends entirely on Enuo, and guidance has already slipped one quarter.
-
Strategic drift. Ten years of delays, a A$176M impairment and governance concerns (executive chair, two of four directors independent, related-party overlap) argue for a persistent discount.
Catalysts and monitorables (next 12 months)
| Catalyst | Expected timing |
|---|---|
| FY2026 Annual Report: going-concern note, audited cash, Thai accounting treatment | Lodged ~29 Sep 2026; verify |
| September quarterly / Appendix 5B | 30 Oct 2026 |
| Completion of the Thai 49% acquisition and issue of US$8M of shares to Enuo | Q4 2026 |
| Thai BOI approval; construction and commissioning milestones | Q4 2026 – Q1 2027 |
| First MREC flake production and first sales contracts | Q1 CY2027 |
| Outcome of Wyloo's sale process and the identity of the new 60% partner | H2 2026 – H1 2027 |
| Definitive Ucore offtake agreement (targeted for June 2026, now overdue) | Unscheduled |
| Capital raising size and price | Likely within 6 months |
| Yangibana FID and financing (including government lenders) | 2,027 |
| NdPr price trajectory and Chinese export policy | Continuous |
Analyst verdict
Hastings Technology Metals today looks very different from the company that spent a decade promising to build Yangibana alone. The 2025 Wyloo restructuring cost shareholders 60% of their flagship and A$176M of book value, but it removed a debt load that had become existential. The company that remains is lean and nearly debt-free, but it is also nearly cash-free. Its value sits in two minority positions it does not control.
The fundamental asset is undeniably good. Yangibana's 37% NdPr ratio, full permitting, more than A$160M of in-situ infrastructure and an updated Stage 1 NPV8 of A$649M against A$333M capex make it one of the more capital-efficient non-China NdPr projects. At about A$62M, the market attributes a small fraction of Hastings' share of that value. That discount reflects funding and control risk, not geology.
The Thailand move is clever but unproven. It offers a cheap ticket, capped at US$15M and largely scrip-funded, to midstream cash flow before Yangibana. However, it depends on an operator-partner that is also the vendor and feedstock supplier, on a plant that has never run, and on a timetable that has already slipped.
The investment case therefore turns on events largely outside Hastings' control: who buys Wyloo's 60% and on what terms, whether Enuo commissions Kabin Buri on schedule, and NdPr pricing. Positive outcomes on two of the three could re-rate the stock several-fold toward attributable NPV. Failure on funding would push Hastings into further dilution or a reduced project stake.
Verdict. This is a high-risk, event-driven special situation. The stock is a cheap option on Western rare earths supply security, but the option premium will likely be paid in dilution. Investors should wait for Thai commissioning evidence and clarity on Wyloo's successor before treating the NPV discount as a margin of safety.
It is not investment advice.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Prior roles | Education |
|---|---|---|---|---|
Charles Lew | Executive Chairman | Director since about 2014; has led Yangibana's advancement since 2014 | MD, ABN Amro investment banking Singapore (1997–2000); founder of Equator Capital; INED, RHB Bank (2004–2016); director, Singapore Medical Group (2007–2013). NED of Metal Bank Ltd since Dec 2025 (fee A$60,000) | BA (Hons) Finance and Accounting, University of East London; MSc Management Science, Imperial College London |
Guy Robertson | Executive Director and Joint Company Secretary | Long-serving | 16 years in the Jardine Matheson group (Finance Director and MD NSW, Jardine Lloyd Thompson; FD/COO, Colliers Asia Pacific); GM Finance, Franklins. Executive Director of Metal Bank, Artemis Resources, Alien Metals; NED of GreenTech Metals | B.Com (Hons), Chartered Accountancy |
Malcolm Randall | Independent Non-Executive Director | — | More than 45 years in resources, including over 25 with Rio Tinto. Non-Executive Chair of Argosy Minerals and Kingsland Minerals; NED of Ora Gold | Diploma/Bachelor of Applied Chemistry; FAICD |
Jean Claude Steinmetz | Independent Non-Executive Director | — | Former COO of Lynas Corporation (Mt Weld and the Malaysian plant); management roles at Rhodia-Solvay, GE and DuPont; chairs a Sino-EU chemical manufacturers committee | BSc Chemical Engineering; MSc Industrial Management |
Neil Hackett | Former Independent NED (retired 12 Jun 2025) | Nov 2018 – Jun 2025 | Chaired the Audit Committee; ESG Committee member | B.Ec (UWA); FINSIA Fellow |
Executive Leadership Team
| Name | Title | Since | Background | Compensation |
|---|---|---|---|---|
Vince Catania | Chief Executive Officer | 12 Jun 2025 (joined Jan 2023 as GM Corporate) | About 18 years as a WA MP (Labor 2005–2009, then Nationals), member for North West Central covering Yangibana; led the Wyloo JV negotiations | Base salary A$340,000 per year on appointment (The West Australian). FY2025 total compensation A$301.2K (Simply Wall St, part-year and pre-CEO) |
Addie Choon | Acting CFO | Apr 2025 | Chartered Accountant (CAANZ); ex-KPMG; former FD of an ASX-listed multinational | — |
Niels Hachmann | Head of Business Development | — | Led the Thailand transaction work (Feb 2026 site visit) | — |
Piyamart Wattanasuyipong | Thailand Business Manager | 2026 | — | — |
Rwi Hau Lim | Construction lead, Thai Hydromet Plant | 2026 | Process engineer with rare earths experience at Lynas Kuantan | — |
Tim Gilbert | Former COO | May 2024 – Dec 2025 | Left to become CEO of Metal Bank | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
H1 FY2023 | Alwyn Vorster as Interim CEO | Transition during early works |
May 2024 | Tim Gilbert promoted to COO | Construction readiness |
Apr 2025 | Addie Choon becomes Acting CFO | — |
12 Jun 2025 | Vince Catania appointed CEO; Neil Hackett retires | After the Wyloo JV binding agreement |
Dec 2025 | Tim Gilbert departs to Metal Bank | Gold divestment |
Major Shareholders
| Holder category | Stake | Source |
|---|---|---|
Insiders | About 14.4–14.6% | AllInvestView aggregator |
Malaco Mining Sdn Bhd | 2,739,726 shares (about 1.2%) | ASX, 23 Jun 2026 |
Enuo Holdings (prospective) | US$8M of new Hastings shares as part of Thai consideration | Term sheet, 31 Mar 2026 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Ticker | Positioning vs Hastings |
|---|---|---|---|
Producing integrated (non-China) | Lynas Rare Earths | ASX: LYC | Largest non-China separated rare earths producer (Mt Weld; Kuantan, Malaysia; Kalgoorlie). Far larger and producing |
Producing integrated (US) | MP Materials | NYSE: MP | Mountain Pass; DoD price-floor partner; magnets |
Monazite and refinery | Iluka Resources | ASX: ILU | Eneabba refinery backed by a government loan; monazite stockpile; a direct competitor for monazite-based processing |
Developer (NT) | Arafura Rare Earths | ASX: ARU | Nolans integrated mine-to-oxide project; larger capex; government-backed |
Developer (NSW) | Australian Strategic Materials | ASX: ASM | Dubbo project and Korean metals plant |
Developer (Vic) | VHM Ltd | ASX: VHM | Goschen mineral sands and rare earths |
Developer (WA) | Northern Minerals | ASX: NTU | Browns Range heavy rare earths |
Developer with a hydromet plant | Lindian Resources | ASX: LIN | Kangankunde (Malawi); also acquired a low-cost hydromet plant in Kazakhstan, a close strategic analogue |
Developer (Brazil) | Meteoric Resources | ASX: MEI | Ionic clay project |
Midstream (US) | Energy Fuels | NYSE: UUUU | Processes monazite at White Mesa, a competitor for monazite feedstock and MREC-type products |
Separation (US) | Ucore Rare Metals | TSXV: UCU | Partner and customer rather than a competitor |
Processing and magnets | Neo Performance Materials | TSX: NEO | Former investee; a potential customer for intermediates |
Chinese incumbents | China Northern Rare Earth; China Rare Earth Group | SSE | Dominant market share; set price |
Peer Comparison FY2025
| Company | Latest FY revenue | Revenue growth | Margin profile | R&D intensity | Status |
|---|---|---|---|---|---|
Hastings (HAS) | A$0 (FY2025) | n/m | n/m (net loss A$222.1M) | — | Pre-revenue |
Lynas (LYC) | About A$556M (FY2025, to Jun-25) | Positive versus FY2024 | Thin margins at FY2025 NdPr prices | Not disclosed here | Producer |
MP Materials (MP) | About US$204M (CY2024) | Decline versus CY2023 | Loss-making in 2024 | Not disclosed here | Producer |
Arafura (ARU) | Nil | n/m | Loss-making | Not disclosed here | Developer |
“—” = not publicly disclosed.
Recent Developments
--



